Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.02 | 1.67 |
NAV | ₹25.86 | ₹216.94 |
Fund Started | 26 Oct 2020 | 20 Aug 2004 |
Fund Size | ₹1879.96 Cr | ₹15520.74 Cr |
Exit Load | Exit load of 1% if redeemed within 3 months. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 23.46% | 25.97% |
3 Year | 20.62% | 25.30% |
5 Year | - | 22.91% |
1 Year
3 Year
5 Year
Equity | 94.69% | 83.32% |
Cash | 5.31% | 16.35% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.08% |
Reliance Industries Ltd. | 6.70% |
ICICI Bank Ltd. | 5.79% |
State Bank of India | 5.58% |
Infosys Ltd. | 4.85% |
ITC Ltd. | 4.82% |
Grasim Industries Ltd. | 4.62% |
Kotak Mahindra Bank Ltd. | 3.99% |
Hindustan Unilever Ltd. | 3.98% |
Indus Towers Ltd. | 3.27% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.49% |
ICICI Bank Ltd. | 9.21% |
Axis Bank Ltd. | 8.35% |
Maruti Suzuki India Ltd. | 4.46% |
SBI Life Insurance Company Ltd. | 4.17% |
Cipla Ltd. | 4.15% |
Kotak Mahindra Bank Ltd. | 3.98% |
HCL Technologies Ltd. | 3.81% |
Bharti Airtel Ltd. | 3.67% |
Piramal Pharma Ltd. | 3.64% |
Name | Fatema Pacha | Dhruv Muchhal |
Start Date | 21 Dec 2020 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of maximum 30 companies across market capitalisation. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 26 Oct 2020 | 20 Aug 2004 |
Description
Launch Date